Yunmin Wu

Yunmin Wu, PhD, currently serves as the Data Analytics and Business Intelligence Lead at ZEISS Medical Technology since July 2022, following a position as Senior Business Analyst. Prior experience includes roles as Consulting Associate and Associate at Charles River Associates from January 2021 to June 2022, and Postdoctoral Researcher at the Max Planck Institute of Neurobiology from October 2015 to December 2020, where contributions included designing imaging and behavior tracking systems and developing automated analysis pipelines. Yunmin Wu also worked as an Analyst Intern at Charles River Associates in early 2020, focusing on market-entry strategies for new therapeutics based on comprehensive market research. Academic credentials include a PhD in Neuroscience from the Graduate School of Systemic Neurosciences at LMU Munich and the International Max Planck Research School for Molecules of Life, as well as a Bachelor of Science in Biochemistry from The Hong Kong University of Science and Technology.